Our Testing Solutions
Serologic Antibody & PCR Testing
Why we offer both serologic & pCR testing
By having the option of using the antibody and/or molecular types of tests, the treating physician can broadly assess where a patient is in the disease process. Those with positive PCR tests and/or positive antibody tests can be isolated from others. They will be advised to notify their contacts so that they can also be quarantined.
Testing for the presence of IgM and IgG antibodies is meant to complement PCR testing in the diagnosis and management of SARS-CoV-2 infections. Both tools are needed for a comprehensive response to infection control .
White gloved drive-thru testing solution with scheduling, billing, logistics, lab testing and telemedicine consultation..
Mitigate litigation risk with employee medical waivers and employer certifications.
All partner manufacturers operate under FDA guidelines.
We Will Help You Every Step Of The Way
When performed on large numbers of people, PCR and Antibody Testing can give a snapshot about community spread and increase our knowledge about the pandemic.
what do you need?
Serology Antibody Assessment
The serologic antibody test has been designed to be specific to antibodies developed to the SARS-CoV-2 virus. It helps determine whether the patient has been exposed to the virus, and may be indicative they are developing immunity to the virus.
Antibodies against SARS-CoV 2 virus are detectable early in the course of infection, usually about 7-10 days after symptoms begin. Some patients infected with SARS-CoV-2 virus never develop symptoms, but still make antibodies. These people are called “asymptomatic carriers”. Antibody tests can be useful in understanding how many people have been infected or exposed, and how far the pandemic has progressed.
We offer a molecular test to diagnose COVID-19 infection. The molecular test is called a “Reverse Transcriptase Polymerase Chain Reaction Test (RT-PCR test)”. PCR tests are used to directly detect the presence of viral RNA in the nasopharyngeal sample. By detecting viral RNA, which will be present in the body before antibodies form or symptoms of the disease are present, the tests can tell whether or not someone has the infection very early on.